Publication: 3488

Publication: 3488

Integration of immunotherapy into adjuvant therapy for resected non-small-cell lung cancer: ALCHEMIST chemo-IO (ACCIO).

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Immunotherapy vol 13 (9) 727-734

Year:: 2021
Type:: Manuscript
Funding:: NCTN
Endpoint:: No-Endpoint
Analysis:: Trial-Description-Only
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: Received

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:

Parents:: 3258
Children:: None

Program:: OGC
Primary Committee:: Respiratory
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882, UG1CA233180, UG1CA233253, UG1CA233247, UG1CA233339, UG1CA232760

Corr. Author:
Authors:: Jacob M Sands Sumithra J Mandrekar David Kozono Geoffrey R Oxnard Shauna L Hillman Dennis A Wigle Ramaswamy Govindan Jennifer Carlisle Jhanelle Gray Joseph K Salama Luis Raez Apar Ganti Nathan Foster Shakun Malik Jeffrey Bradley Karen Kelly Suresh S Ramalingam Thomas E Stinchcombe

Networks:: CORA, FL023, FL065, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-NC010, NE003

Study: Alliance-A081801
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords:: NSCLC, adjuvant chemotherapy, lung adenocarcinoma, lung squamous cell carcinoma, pembrolizumab